Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Positive effects of antihypertensive treatment on aortic stiffness in the general population

J. Seidlerová, J. Filipovský, O. Mayer, P. Wohlfahrt, R. Cífková,

. 2014 ; 37 (1) : 64-8.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Aortic stiffness is strongly related to age and mean arterial pressure (MAP). In the present analysis, we investigated whether antihypertensive treatment modulates the association of the aortic pulse wave velocity (PWV) with age and with MAP in the general population. In the Czech post-MONICA cross-sectional study, we measured the PWV in 735 subjects (mean age 61.2±7.8 years, 54.1% women, 44.3% on antihypertensive medication). We used a linear regression model to assess the effect of treatment on the PWV. The independent covariates in our analysis included sex, age, MAP, heart rate, body mass index, plasma glucose, low-density lipoprotein cholesterol, smoking and observer. The patients receiving treatment were older (64.1±6.7 vs. 58.9±7.8 years), had higher systolic blood pressure (135.9±16.2 vs. 130.1±16.5 mm Hg) and had higher pulse wave velocity (9.1±2.2 vs. 8.2±2.1 m s(-1); P for all <0.0001) than untreated subjects. After adjustment for MAP, the use of treatment modified the association between age and the PWV (regression equations, treated patients 9.68-0.009 × age vs. untreated subjects 6.98+0.020 × age, difference of regression slopes, F=11.2; P=0.0009). In analyses adjusted for age, treatment was associated with a smaller increase of the PWV with MAP (treated patients 9.63-0.006 × MAP vs. untreated subjects 7.18+0.010 × MAP, F=10.70; P=0.0001). These results were driven primarily by subjects whose blood pressure was below 140/90 mm Hg. In the cross-sectional analysis from a random sample of the general population, antihypertensive treatment was associated with a less steep increase in the PWV with age and the mean arterial pressure. Further longitudinal studies are needed to confirm this finding.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14074650
003      
CZ-PrNML
005      
20141008122704.0
007      
ta
008      
141006s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/hr.2013.113 $2 doi
035    __
$a (PubMed)24048486
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Seidlerová, Jitka $u 1] Department of Internal Medicine II, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic [2] Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.
245    10
$a Positive effects of antihypertensive treatment on aortic stiffness in the general population / $c J. Seidlerová, J. Filipovský, O. Mayer, P. Wohlfahrt, R. Cífková,
520    9_
$a Aortic stiffness is strongly related to age and mean arterial pressure (MAP). In the present analysis, we investigated whether antihypertensive treatment modulates the association of the aortic pulse wave velocity (PWV) with age and with MAP in the general population. In the Czech post-MONICA cross-sectional study, we measured the PWV in 735 subjects (mean age 61.2±7.8 years, 54.1% women, 44.3% on antihypertensive medication). We used a linear regression model to assess the effect of treatment on the PWV. The independent covariates in our analysis included sex, age, MAP, heart rate, body mass index, plasma glucose, low-density lipoprotein cholesterol, smoking and observer. The patients receiving treatment were older (64.1±6.7 vs. 58.9±7.8 years), had higher systolic blood pressure (135.9±16.2 vs. 130.1±16.5 mm Hg) and had higher pulse wave velocity (9.1±2.2 vs. 8.2±2.1 m s(-1); P for all <0.0001) than untreated subjects. After adjustment for MAP, the use of treatment modified the association between age and the PWV (regression equations, treated patients 9.68-0.009 × age vs. untreated subjects 6.98+0.020 × age, difference of regression slopes, F=11.2; P=0.0009). In analyses adjusted for age, treatment was associated with a smaller increase of the PWV with MAP (treated patients 9.63-0.006 × MAP vs. untreated subjects 7.18+0.010 × MAP, F=10.70; P=0.0001). These results were driven primarily by subjects whose blood pressure was below 140/90 mm Hg. In the cross-sectional analysis from a random sample of the general population, antihypertensive treatment was associated with a less steep increase in the PWV with age and the mean arterial pressure. Further longitudinal studies are needed to confirm this finding.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a stárnutí $x fyziologie $7 D000375
650    _2
$a antihypertenziva $x terapeutické užití $7 D000959
650    _2
$a aorta $x účinky léků $x fyziologie $7 D001011
650    _2
$a průřezové studie $7 D003430
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x farmakoterapie $x patologie $x patofyziologie $7 D006973
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a statistické modely $7 D015233
650    _2
$a analýza pulzové vlny $7 D063177
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a tuhost cévní stěny $x účinky léků $7 D059289
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Filipovský, Jan $u 1] Department of Internal Medicine II, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic [2] Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.
700    1_
$a Mayer, Otto $u 1] Department of Internal Medicine II, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic [2] Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.
700    1_
$a Wohlfahrt, Peter $u 1] Centre for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic [2] Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Cífková, Renata $u 1] Centre for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic [2] Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
773    0_
$w MED00006041 $t Hypertension research : official journal of the Japanese Society of Hypertension $x 1348-4214 $g Roč. 37, č. 1 (2014), s. 64-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24048486 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20141008123052 $b ABA008
999    __
$a ok $b bmc $g 1042533 $s 873562
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 37 $c 1 $d 64-8 $i 1348-4214 $m Hypertension research $n Hypertens Res $x MED00006041
LZP    __
$a Pubmed-20141006

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...